Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN) [Phase 1, Phase 2]
This is a dose-escalating Phase 1/2 trial evaluating obinutuzumab in CD20+ malignant diseases (lymphoma). The study has completed and result…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]
Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 pilot trial evaluating radiation-enhanced allogeneic cell therapy for progressive hematologic malignancies after allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 [Phase 2]
Extension phase 2 study update for YM-155 in prostate cancer, melanoma, and non-Hodgkin lymphoma; status completed.
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial results evaluating chemotherapy with or without total-body irradiation followed by stem cell transplant in patients with Non-H…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial comparing subcutaneous versus intravenous rituximab in follicular non-Hodgkin's lymphoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach [Phase 2]
Phase 2 trial evaluating an anti-angiogenic approach for relapsed lymphoid malignancies, including Non-Hodgkin lymphoma, has been terminated…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms [Phase 1]
Termination of a Phase 1 trial evaluating oral azacitidine (CC-486) in Japanese subjects with hematological neoplasms.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma [Phase 3]
This is a Phase 3 clinical trial update evaluating MabThera (rituximab) in patients with advanced non-Hodgkin lymphoma. Results from the stu…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [Phase 3]
A Phase 3 trial investigating treatment for graft-versus-host disease in patients with recurrent or refractory lymphoma or Hodgkin's disease…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy [Phase 2, Phase 3]
This update summarizes a Phase 2/Phase 3 study of StemEx for high-risk hematologic malignancies after myeloablative therapy, focusing on eff…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
This entry reports a completed clinical trial evaluating the psychosexual impact of cancer-related infertility in women and the role of thir…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 in combination with azacitidine (Vidaza) for relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and biological activity of oral clioquinol in patients with relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I Study of OPB-51602 in Patients With Hematologic Malignancies [Phase 1]
Phase I trial results are reported for OPB-51602 in patients with hematologic malignancies including multiple myeloma, non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. [Phase 4]
Phase 4 study evaluating maintenance rituximab (MabThera) in patients with Non-Hodgkin's Lymphoma has completed; results were posted in 2015…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]
Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myelo…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update reporting completion of a study evaluating interleukin-12 in patients with various previously treated non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL) [Phase 1, Phase 2]
This report summarizes the completion and results posting of a Phase 1/2 trial evaluating Bendamustine plus Bortezomib in indolent non-Hodgk…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma [Phase 1]
This is a Phase 1 trial evaluating a chemotherapy regimen followed by autologous stem cell transplantation and white blood cell infusions in…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL [Phase 1, Phase 2]
A Phase 1/2 trial of rituximab plus CAMPATH in relapsed/refractory CD20-positive B-cell non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). [Phase 3]
Phase 3 open-label, single-arm trial evaluating safety and efficacy of Plerixafor with G-CSF for front-line mobilization in lymphoma and mul…
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) [Phase 1]
This is a phase 1 study of a triple-drug regimen (bendamustine, lenalidomide, and rituximab) in chronic lymphocytic leukemia and non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of sirolimus in pediatric patients with relapsed or refractory acute leukemia or non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies [Phase 1]
A Phase I trial evaluating vorinostat in combination with niacinamide and etoposide for Hodgkin's disease and non-Hodgkin's lymphoma has com…